| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2960769 | Journal of Cardiac Failure | 2008 | 6 Pages |
Abstract
BiVAD implantation remains one of the challenges in treating severe heart failure. Previous cardiac surgery, elevated creatinine, and post-LVAD extracorporeal membrane oxygenation were risk factors for mortality after BiVAD implantation. Dialated Cardiomyopathy on the other hand was associated with a more favorable outcome.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Firas MD, Yoshio MD, PhD, Randall C. MD, MPH, Nicholas G. MD, Mohamad MD, Lucy MS, Kiyotaka MD, PhD,